Genetic Technologies Limited (GENE)
NASDAQ: GENE · Real-Time Price · USD
0.765
0.00 (0.00%)
Nov 14, 2024, 4:00 PM EST - Market closed
Genetic Technologies Employees
Genetic Technologies had 55 employees as of June 30, 2024. The number of employees decreased by 5 or -8.33% compared to the previous year.
Employees
55
Change (1Y)
-5
Growth (1Y)
-8.33%
Revenue / Employee
$117,340
Profits / Employee
-$145,780
Market Cap
3.78M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 55 | -5 | -8.33% |
Jun 30, 2023 | 60 | 8 | 15.38% |
Jun 30, 2022 | 52 | 34 | 188.89% |
Jun 30, 2021 | 18 | - | - |
Related Stocks
Company Name | Employees |
---|---|
China Pharma Holdings | 231 |
Hepion Pharmaceuticals | 22 |
Windtree Therapeutics | 20 |
Sonoma Pharmaceuticals | 10 |
Azitra | 10 |
Pasithea Therapeutics | 8 |
Artelo Biosciences | 6 |
Aptorum Group | 3 |
GENE News
- 6 weeks ago - BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Accesswire
- 2 months ago - Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2 - GlobeNewsWire
- 2 months ago - Genetic Technologies Invited to Join Prestigious “CancerIQ” Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics - GlobeNewsWire
- 4 months ago - Genetic Technologies Strategic Restructure Driving USA Sales Growth - GlobeNewsWire
- 4 months ago - Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary - GlobeNewsWire
- 5 months ago - GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease - GlobeNewsWire
- 5 months ago - Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27 - GlobeNewsWire
- 7 months ago - Appendix 4C & Quarterly Business Update – March 2024 - GlobeNewsWire